J
José Luis Zamorano
Researcher at Carlos III Health Institute
Publications - 740
Citations - 154643
José Luis Zamorano is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 105, co-authored 695 publications receiving 133396 citations. Previous affiliations of José Luis Zamorano include Hospital Clínico San Carlos & Universidad Francisco de Vitoria.
Papers
More filters
COVID-19 y shock cardiogénico: diferentes formas de presentación cardiovascular con alta mortalidad./ [COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality].
Ángel Sánchez-Recalde,Jorge Solano-López,Javier Miguelena-Hycka,Jesús Javier Martín-Pinacho,Marcelo Sanmartín,José Luis Zamorano +5 more
Journal ArticleDOI
Integrin-Linked Kinase Expression in Human Valve Endothelial Cells Plays a Protective Role in Calcific Aortic Valve Disease
Sandra Sánchez-Esteban,Mercedes Castro-Pinto,Alberto Cook-Calvete,Paula Reventun,María Delgado-Marín,Lucía Benito-Manzanaro,Ignacio Hernandez,Jose López-Menéndez,José Luis Zamorano,Carlos Zaragoza,Marta Saura +10 more
TL;DR: It is determined that ILK expression is downregulated in aortic valves from patients with CAVD compared to non-CAVD, especially at the valve endothelium, and negatively correlated with calcification markers.
Journal ArticleDOI
Utilidad de las alteraciones especulares en el diagnóstico del infarto con elevación mínima del segmento ST
David Martí,Luisa Salido,José Luis Mestre,Eduardo Casas,María Jesús Esteban,José Luis Zamorano +5 more
Journal ArticleDOI
Inverted McConnell sign.
Jose Alberto de Agustin,Pedro Marcos-Alberca,Covadonga Fernández-Golfín,Gisela Feltes,Carlos Almería,Carlos Macaya,José Luis Zamorano +6 more
TL;DR: Considering such large bilateral pulmonary embolism and severe right ventricular dysfunction, fibrinolytic therapy with alteplase was administered and both dyspnea and resting hypoxia improved.
Journal ArticleDOI
Teofilina para o Alívio da Dispneia Relacionada ao Ticagrelor
TL;DR: Theophylline has been used as a bronchodilator since 1922, and its effects seem to be partly mediated through nonselective adenosine receptors blockade.